CH429739A - Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten - Google Patents

Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten

Info

Publication number
CH429739A
CH429739A CH54863A CH54863A CH429739A CH 429739 A CH429739 A CH 429739A CH 54863 A CH54863 A CH 54863A CH 54863 A CH54863 A CH 54863A CH 429739 A CH429739 A CH 429739A
Authority
CH
Switzerland
Prior art keywords
alkylxanthine
derivatives
preparation
basic substituted
substituted
Prior art date
Application number
CH54863A
Other languages
English (en)
Inventor
Karl-Heinz Dr Klingler
Schlichtegroll Ansgar Dr Von
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of CH429739A publication Critical patent/CH429739A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH54863A 1962-03-30 1963-01-17 Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten CH429739A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DED38531A DE1221641B (de) 1962-03-30 1962-03-30 Verfahren zur Herstellung von basisch substituierten Theophyllinderivaten

Publications (1)

Publication Number Publication Date
CH429739A true CH429739A (de) 1967-02-15

Family

ID=7044170

Family Applications (1)

Application Number Title Priority Date Filing Date
CH54863A CH429739A (de) 1962-03-30 1963-01-17 Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten

Country Status (5)

Country Link
BE (1) BE630294A (de)
BR (1) BR6347019D0 (de)
CH (1) CH429739A (de)
DE (1) DE1221641B (de)
GB (1) GB1006137A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560389A (en) 1976-12-14 1980-02-06 Degussa Bascically substituted theophylline derivatives
DE3028272A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte alkylamino-desoxy-1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1100642B (de) * 1956-09-25 1961-03-02 Chemiewerk Homburg Verfahren zur Herstellung von basisch substituierten Alkylxanthin-derivaten
DE1123329B (de) * 1958-10-18 1962-02-08 Chemiewerk Homburg, Zweigniederlassung der Deutschen Gold- und Silber Scheideanstalt vormals Roessler, Frankfurt/M Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten.
DE1124041B (de) * 1959-06-10 1962-02-22 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Xanthinderivate

Also Published As

Publication number Publication date
BE630294A (fr) 1963-07-15
BR6347019D0 (pt) 1973-07-19
GB1006137A (en) 1965-09-29
DE1221641B (de) 1966-07-28

Similar Documents

Publication Publication Date Title
CH458394A (de) Verfahren zur Herstellung von B-Amino-acylphenyl-Verbindungen
CH436320A (de) Verfahren zur Herstellung von Acylmelaminverbindungen
CH445514A (de) Verfahren zur Herstellung von 6-Alkylmorphinan-Derivaten
CH426830A (de) Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-derivaten
CH430677A (de) Verfahren zur Herstellung von p-Aminoarylaldehyden
CH438350A (de) Verfahren zur Herstellung von 6-Hydroxy-morphinan-Derivaten
AT240865B (de) Verfahren zur Herstellung von neuen Thiaxanthen-Derivaten
AT242863B (de) Verfahren zur Herstellung von α-Amino-arylmethylpenicillinen
CH415612A (de) Verfahren zur Herstellung von 19-Nor-steroidverbindungen
AT250582B (de) Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden
CH460036A (de) Verfahren zur Herstellung von Morphinan-Derivaten
CH427812A (de) Verfahren zur Herstellung von Oxathiazolinonen
CH431511A (de) Verfahren zur Herstellung von 1a-Alkylthio-3-keto-steroiden
CH429729A (de) Verfahren zur Herstellung von Aminoisoxazolen
CH475985A (de) Verfahren zur Herstellung von substituierten 2-Oxo-tetrahydrochinolinen
CH418336A (de) Verfahren zur Herstellung von Octahydrophenanthridinverbindungen
AT241433B (de) Verfahren zur Herstellung von N-Trifluormethyl-N-aryl-aminosulfensäurehalogeniden
CH431518A (de) Verfahren zur Herstellung von 16B-Niederalkylthio-17B-hydroxy-östren-3-onen
CH475932A (de) Verfahren zur Herstellung von Hydrindacenverbindungen
AT257064B (de) Verfahren zur Herstellung von 16α-Hydroxysteroiden
AT242149B (de) Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin
CH450443A (de) Verfahren zur Herstellung von Morphinan-Derivaten
CH430735A (de) Verfahren zur Herstellung von 2-Hydroxy-s-triazinen
CH431510A (de) Verfahren zur Herstellung von Diacylcymarol
CH428750A (de) Verfahren zur Herstellung von N-Trifluormethylaminen